Takahashi Y,Sawada G,Kurashige J,et al.Amplification of PVT-1is involved in poor prognosis via apoptosis inhibition in colorectal cancers[J].Br J Cancer,2014,110(6):164-171.
[2]
Wang KC,Chang HY.Molecular mechanisms of long noncoding RNAs[J].Mol Cell,2011,43(3):904-914.
[3]
Li SP,Xu HX,Yu Y,et al.LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1signaling pathway[J].Oncotarget,2016,7(27):42 431-42 446.
[4]
Yuan SX,Yang F,Yang Y,et al.Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as apredictor for hepatocellular carcinoma patients'poor recurrence-free survival after hepatectomy[J].Hepatology,2012,56(6):2 231-2 241.
[5]
Sung JJ,Ng SC,Chan FK,et al.An updated Asia Pacific Consensus Recommendations on colorectal cancer screening[J].Gut,2015,64(1):121-132.
[6]
Mercer TR,Dinger ME,Mattick JS.Long non-coding RNAs:insights into functions[J].Nat Rev Genet,2009,10(3):155-159.
[7]
rom UA,Derrien T,Beringer M,et al.Long noncoding RNAs with enhancer-like function in human cells[J].Cell,2010,143(1):46-58.
[8]
Lu Z,Xiao Z,Liu F,et al.Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1(SPHK1)[J].Oncotarget,2016,7(1):241-254.
[9]
Sun C,Huang C,Li S,et al.Hsa-miR-326targets CCND1and inhibits non-small cell lung cancer development[J].Oncotarget,2016,7(7):8 341-8 359.
[10]
Kanthan R,Senger JL,Kanthan SC.Molecular events in primary and metastatic colorectal carcinoma:a review[J].Patholog Res Int,2012,2012:597 497.
[11]
Ji P,Diederichs S,Wang W,et al.MALAT-1,a novel noncoding RNA,and thymosin beta4predict metastasis and survival in early-stage non-small cell lung cancer[J].Oncogene,2003,22(39):8 031-8 041.
[12]
DeSantis CE,Lin CC,Mariotto AB,et al.Cancer treatment and survivorship statistics,2014[J].CA Cancer J Clin,2014,64(4):252-271.
[13]
Jin C,Shi W,Wang F,et al.Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer[J].Oncotarget,2016,7(32):51 763-51 772.
[14]
Peng W,Wu J,Feng J.Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma[J].Biomed Pharmacother,2016,79:188-193.
